Published • loading... • Updated
AstraZeneca Tablet for Obesity Helps Patients Lose 10.5% of Weight
Summary by Publico
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Patients lost 10.5% of their weight in 26 weeks in an intermediate trial of the AstraZeneca experimental pill, which wants to compete in the market for weight loss with Novo Nordisk and Eli Lilly.
·Portugal
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
